医疗器械行业：外周介入国采进行时，国产替代进程持续推进
广发证券·2024-12-19 01:48
剧风险。 [Table_Contacts] [Table_Page] 跟踪分析|医疗器械 | --- | --- | --- | --- | |-------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ...